Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan · Delayed Price · Currency is TWD 110.00
-7.50 (-6.38%)
At close: Jul 9, 2026
Gongwin Biopharm Holdings Market Cap
Gongwin Biopharm Holdings has a market cap or net worth of 13.33 billion as of July 9, 2026. Its market cap has increased by 4.38% in one year.
Market Cap
13.33B
Enterprise Value
11.92B
Revenue
38.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
110.00
Market Cap Chart
Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 13.33B, an increase of 50.38%. That is a compound annual growth rate of 4.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 13.33B | 26.29% |
| Dec 31, 2025 | 10.56B | -26.53% |
| Dec 31, 2024 | 14.37B | -31.28% |
| Dec 29, 2023 | 20.91B | -42.13% |
| Dec 30, 2022 | 36.13B | 16.16% |
| Dec 30, 2021 | 31.10B | 17.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lumosa Therapeutics | 17.00B |
| Ever Supreme Bio Technology | 16.44B |
| EirGenix | 15.57B |
| Medigen Vaccine Biologics | 15.53B |
| ACRO Biomedical | 12.78B |
| Polaris Group | 11.91B |
| Tanvex BioPharma | 10.94B |
| Locus Cell | 9.17B |